If levels don't respond to standard supplementation, investigate possible MTHFR polymorphisms, malabsorption conditions like celiac or Crohn's disease, or potential medication interactions
doi: 10.1016/j.mib.2017.10.018 363 SeagleE
Lipid nanoparticles improve the uptake of -Asarone into the brain parenchyma: formulation, characterization, in vivo pharmacokinetics, and brain delivery
Uses patented HINNAO lipid technology for fast delivery
fabricated an intelligent nanocatalytic material consisting of copper-doped calcium phosphate (CuCaP) NPs, PEG-modified glucose oxidase (GOx), and the chemotherapeutic drug doxorubicin (DOX) PGC-DOX for efficient cancer therapy ( 2+ , and DOX will be released in response to acidic environments